Fig. 6From: In silico analysis of HLA-1 and HLA-2 recognition of a designed recombinant human papillomavirus vaccine based on L1 protein HPV subtype 45A Sequence of L1 HPV45 protein that had been previously optimised as a VLP vaccine candidate [5], B prediction of its secondary, and C tertiary structuresBack to article page